Industry News
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
CellCAN and CCRM Partner to Launch CATTI
New Institute will tackle gaps in training Canada’s GMP workforce.07.29.21
-
Breaking News | Facilities | Industry News
Regeneron Investing Nearly $2B in Tarrytown, NY Campus
New York's largest biotech company creating an additional 1,000 jobs over five years.07.29.21
-
Breaking News | Facilities | Industry News
Nexus Pharmaceuticals Opens State-of-the-Art Manufacturing Facility
Phase I investment of $100 million supports a new three-story manufacturing facility.07.29.21
-
Breaking News | Facilities | Industry News
Celanese Opens Pharma Drug Delivery Feasibility Lab
State-of-the-art R&D lab at Florence, KY site expands technical feasibility capabilities for long-acting delivery of small molecules, biologics and nucleotides.07.29.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Akston Biosciences, Seppic Ink Commercial Supply Agreement
Deal is for an adjuvant to formulate shelf-stable COVID-19 vaccine at global scale.07.29.21
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Abzena, BioXpress Therapeutics Enter Biosimilar Tie-up
Partnership to support the development and manufacture of biosimilars for global customers.07.29.21
-
Breaking News | Industry News | Promotions & Moves
SCA Pharma Names Scott Luce as CEO
Luce’s priorities include serving new customer segments and fulfilling the company’s ambitious construction plan to expand capacity.07.29.21
-
Breaking News | Industry News | Promotions & Moves
Sterling Pharma Solutions Appoints Ian Baxendale to Lead Team at Dudley, UK Site
Baxendale has over 20 years of academic and industrial experience within organic synthesis.07.29.21
-
Breaking News | Industry News
Amgen to Acquire Teneobio for $900M
Includes Teneobio's bispecific and multispecific antibody technologies, heavy-chain only platform and T-cell engager platform.07.28.21
-
Breaking News | Clinical Trials | Drug Development | Industry News | Information Technology
Almac, THREAD to Integrate Technologies for Clinical Trials
Integrating technology platforms aims to provide sponsors and CROs with a full range of tools designed to reduce the risk of trial delays.07.28.21
-
Breaking News | Drug Development | Industry News
Lantern Pharma Reacquires Irofulven from Allarity Therapeutics
Based on early Phase II results, Lantern to advance development in bladder and prostate cancer with a key mutation in the ERCC2/3 genes.07.28.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
ValenzaBio, ProBioGen Enter Cell Line Pact
Aims to maximize cell line productivity leveraging ProBioGen's GlymaxX technology for ValenzaBio's clinical-stage antibody.07.28.21
-
Breaking News | Industry News | Laboratory Testing
Cerba Research Wins NIH Contract for Central Lab Services
To provide clinical lab screening and safety testing for NIAID-supported clinical trials in the area of infectious disease.07.28.21
-
Breaking News | Facilities | Industry News
Archimica Completes Expansion of Its Multi-Purpose Manufacturing Capacity
Recent investment adds significantly to the company's capabilities.07.27.21
-
Breaking News | Collaborations & Alliances | Industry News
CatSci and Argonaute RNA Enter CMC Development Collaboration
Aim to expedite oligonucleotide manufacturing for gene-silencing therapeutics.07.27.21
-
Breaking News | Industry News | Promotions & Moves
Genezen Laboratories Appoints Brok Weichbrodt as VP of Operations
Further strengthens its senior leadership team.07.27.21
-
Breaking News | Collaborations & Alliances | Facilities | Industry News
Grifols Expands Activity in Africa
Will set up an intravenous solutions manufacturing plant in Nigeria.07.27.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
AavantiBio, Aldevron Form Gene Therapy Partnership
Aldevron will supply plasmids to AavantiBio’s planned vector core and CDMO partners.07.27.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Alloy Therapeutics, Echo Investment Capital Create Wheeler Bio
New company set up to accelerate the development of new antibody therapeutics.07.27.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Capsida Unveils Next-Generation Gene Therapy Manufacturing
New 15,000 square foot facility in Thousand Oaks will enable end-to-end gene therapy manufacturing capability.07.27.21
